PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Jul-2024 Global Pediatric Spasticity Treatment Market Set for Remarkable Growth: Forecasted CAGR of 10% from 2022 to 2032 MARKITWIRED
12-Jul-2024 Global Cell Regeneration Medicine Market Projected to Reach USD 130.8 Billion by 2032 MARKITWIRED
12-Jul-2024 Global Intubation Tube Market Projected to Reach USD 4.5 Billion by 2032 MARKITWIRED
12-Jul-2024 Global Dental Chair Market Projected to Reach USD 851 Million by 2032, Driven by Rising Demand for Dental Aesthetics | FMI MARKITWIRED
12-Jul-2024 Pharma CCO Market Forecasts 5% CAGR by 2029, Highlighting Real-World Evidence Demand Medi-Tech Insights
12-Jul-2024 Cold Pain Therapy Market Size Projected to Grow at a CAGR of 8.22% by 2032 Value Market Research
11-Jul-2024 Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024 AccessWire
11-Jul-2024 Promising Data on Transdermal Obesity Formulations Announced by Skinvisible AccessWire
11-Jul-2024 AGFA HealthCare and Corista Announce North America Launch of its Integrated Solution for Digital Transformation in Pathology AccessWire
11-Jul-2024 Socioeconomic status significantly affects fertility treatment outcomes, new study shows European Society of Human Reproduction and Embryology
11-Jul-2024 Familial endocrine diseases linked to increased risk of pregnancy loss, new research shows European Society of Human Reproduction and Embryology (ESHRE)
11-Jul-2024 Envirotainer invests in new testing chambers to drive innovation Envirotainer
11-Jul-2024 Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors Quell Therapeutics
11-Jul-2024 Eurofins Acquires Leading UK Healthcare Water Testing Laboratory Eurofins Food & Water Testing UK
11-Jul-2024 Concr launches trial using digital twins for outcome prediction in breast cancer Concr
11-Jul-2024 NICE recommends Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England in eligible adolescents and adults Almirall
11-Jul-2024 Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis Q32 Bio Inc
11-Jul-2024 validation of its AAA EndoStapling solution Aortoseal Endoron Medical
11-Jul-2024 Simris Biologics enters into a collaboration agreement with New Zealand Universities to develop peptide drug conjugates (PDC) Simris Group AB
11-Jul-2024 Cambridge Cognition secures Innovate UK grant for Bio-Hermes 2 project Cambridge Cognition Holdings plc